Counterfeit Version of Avastin In U.S. Distribution
Article | February 17, 2012
The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.
The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy.
Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.
Accelerate Brain Cancer Cure is a Washington DC-based venture philanthropy 501(c)(3) nonprofit organization that drives cutting-edge research and treatments for brain tumors. Copyright 2014 ABC2 - All Rights Reserved.